The U.S. Drug Enforcement Agency (DEA; Springfield, VA) announced that it has classified boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as anabolic steroids under the Controlled Substances Act, according to the Natural Products Association (NPA; Washington, DC). This ruling will be made effective January 4, 2010.
The U.S. Drug Enforcement Agency (DEA; Springfield, VA) announced that it has classified boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as anabolic steroids under the Controlled Substances Act, according to the Natural Products Association (NPA; Washington, DC). This ruling will be made effective January 4, 2010.
NPA released a press release, last week, commending the action by DEA. 'The association has maintained all along that federal regulators have the authority they need [to schedule these substances],'ÃÂ said John Gay, executive director and CEO of NPA. 'The DEA...s listing of these three steroids demonstrates that federal regulators can indeed safeguard the shelves against these substances.'ÃÂ
The classified substances received increased scrutiny during talks at a September Senate hearing on 'hidden steroids'ÃÂ held by the Senate Subcommittee on Crime and Drugs. DEA first received notice for proposed rulemaking on the substances in April 2008. The agency also states that, since August 2008, it has been aware of 58 dietary supplements believed to contain one or more of these substances.
DEA...s full announcement can be read here
Standardized valerian extract shows acute sleep benefits after one day, says recent study
December 10th 2024Results showed that after a single dose, people taking the Valerian extract experiences an acute benefit on sleep, namely a significant increase in actual sleep time compared to baseline.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.